TrialJectory is an organization working to match bladder, breast, colorectal, melanoma, myelodysplastic syndromes (MDS), and other cancer patients with the clinical trial that is right for them. They have successfully raised 2.7 million dollars to advance their development, add more cancers to their list, and expand their outreach.

This organization is in contact with patients, caregivers, and pharmaceutical companies, with the goal of providing all patients the access to treatment that every human being deserves.

How it Works

TrialJectory works by using artificial intelligence to match patients to clinical trials. Patients fill out a simple online questionnaire. Keywords are then extracted from this questionnaire and analyzed. These words help to highlight the most important medical attributes of a patient which may impact their trial fit and eligibility. Information is grouped into clusters and standardized.

Looking Forward

This organization is led by technology experts and leaders in oncology. The team is excited about their progress, not only because of the medical aid they may be able to provide patients, but the empowerment it can give them to control their own care.

We all know how difficult it can be to find the right treatment, even when working with the most intelligent and dedicated medical professional. TrialJectory could help improve personalized medicine.

The ultimate goal is that TrialJectory will evolve into a go-to resource for healthcare professionals around the world. Patients will be matched to personalized treatments faster, improving their quality of life and overall outcomes.